Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.
Observe Medical is listed on Euronext Oslo under OBSRV.
| Documents for the Annual General Meeting 29 May 2026 can be found here , or by scrolling down to the governance section and “General Meeting” |
Oslo, 29 May 2026 The annual general meeting of Observe Medical ASA (the "Company" or "Observe Medical", Euronext Expand ticker "OBSRV") was held today, on 29 May 2026 at 10:00 hours (CEST), at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway. All resolutions were made in accordance with the proposals from the board of…
Oslo, 8 May 2026 – Observe Medical ASA (OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, 29 May 2026, at 10:00 (CEST). The annual general meeting will be held at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway. The notice of the annual general meeting is attached, together with the…
Oslo, April 30, 2026 – Observe Medical ("the Company" or "Observe Medical") has today published its Annual Report for 2025. The report is attached to this notice in ESEF and PDF format and is also available on the company's website under the Investor Relations section. This information is subject to the disclosure requirements pursuant to Section 5-12 of… Observe Medical ASA – Annual General Meeting held
Observe Medical ASA – Notice of Annual General Meeting
Observe Medical Annual Report for 2025
Follow the development of the Observe Medical share at Oslo Stock Exchange under the OBSRV ticker. Observe Medical ASA has been listed on the Oslo Stock Exchange since November 4, 2019.
To view all stock exchange releases form the Company, please review Oslo Stock Exchange NewsWeb under the OBSRV ticker.
As at 4 May 2026
| Name | Number of shares | % of top 20 | % of total | Country | ||
|---|---|---|---|---|---|---|
| 1 | R INVESTMENT COMPANY AS | 10 703 684 | 12.15% | 7.86% | Norway | |
| 2 | SONGA CAPITAL AS | 10 000 000 | 11.35% | 7.34% | Norway | |
| 3 | NAVAMEDIC ASA | 7 664 279 | 8.70% | 5.63% | Norway | |
| 4 | JPB AS | 7 170 996 | 8.14% | 5.27% | Norway | |
| 5 | KING KONG INVEST AS | 6 333 333 | 7.19% | 4.65% | Norway | |
| 6 | JIANGSU HONGXIN MEDICAL TECHNOLO | 6 000 000 | 6.81% | 4.41% | CHINA | |
| 7 | BJØRNTVEDT, VEGARD | 5 566 867 | 6.32% | 4.09% | NORWAY | |
| 8 | SEED CAPITAL AS | 5 236 268 | 5.12% | 3.82% | Norway | |
| 9 | EIDCO AS | 4 000 000 | 4.54% | 2.94% | Norway | |
| 10 | RO, LARS | 3 400 000 | 3.86% | 2.50% | Norway | |
| 11 | GLIMT INVEST AS | 3 187 713 | 3.62% | 2.34% | Norway | |
| 12 | EM KAPITAL AS | 2 800 000 | 3.18% | 2.06% | NORWAY | |
| 13 | LIVERMORE INVEST AS | 2 386 439 | 2.71% | 1.75% | Norway | |
| 14 | SONGA X AS | 2 100 000 | 2.38% | 1.54% | Norway | |
| 15 | JJB AS | 2 100 000 | 2.38% | 1.54% | Norway | |
| 16 | AGMABLY AS | 2 100 000 | 2.38% | 1.54% | Norway | |
| 17 | AKB AS | 2 100 000 | 2.38% | 1.54% | Norway | |
| 18 | GINNY INVEST AS | 1 800 000 | 2.04% | 1.32% | Norway | |
| 19 | ABAGUST AS | 1 750 000 | 1.99% | 1.29% | Norway | |
| 20 | NORDNET LIVSFORSIKRING AS | 1 668 344 | 1.89% | 1.23% | Norway | |
| Total number owned by top 20 | 88 067 923 | 100.00% | 64.69% | |||
| Total number of shares | 136 148 412 | |||||
| Total number of shareholders | 2 450 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Kathrine Gamborg Andreassen.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no
29 May 2026:
10 October 2025:
3 July 2025:
27 June 2025:
7 January 2025:
17 July 2024: Observe Medical ASA – Minutes from Extraordinary General Meeting
26 June 2024: Observe Medical ASA – Notice of Extraordinary General Meeting
24 May 2024: Observe Medical ASA – Minutes from Annual General Meeting
3 May 2024: Notice of Annual General Meeting on 24 May 2024, including attendance, advance vote, and proxy forms
3 May 2024: Nomination Committee recommendation
3 May 2024: Observe Medical – Report of salary and other remuneration to leading personnel
22 November 2023: Observe Medical ASA – Minutes Extraordinary General Meeting
1 November 2023: Attendance and proxy form to the extraordinary general meeting
Shareholders who receive the notice electronically must log in to investor services (click on events, general meeting) for their registration
1 November 2023: Observe Medical ASA – Notice of Extraordinary General Meeting 22 November 2023
26 May 2023: Observe Medical ASA – Minutes from Annual General Meeting
26 May 2023: Represented List
5 May 2023:Notice of Annual General Meeting on 26 May 2023
5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023
5 May 2023: VPS – Investor services
5 May 2023: Nomination Committee recommendation
5 May 2023: Observe Medical – Report of salary and other remuneration to leading personnel
3 June 2022: Minutes from Annual General Meeting 2022
3 June 2022: Represented list
31 May 2022: Board of Directors recommendation for appointment of auditor
31 May 2022: The Nomination Committee recommendation part 2
13 May 2022: Notice of Annual General Meeting on 3 June 2022
13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
13 May 2022: The Nomination Committee’s recommendation (part 1)
13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
13 May 2022: Report on salary and other remuneration to executive personnel year 2021
13 May 2022: VPS – Investor services
13 May 2022: LUMI
13 May 2022: Online guide LUMI (Norsk)
13 May 2022: Online guide LUMI (English)
4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee’s recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
Jørgen Mann, Chief Executive Officer
+45 40 86 75 58 / jørgen.mann@observemedical.com
Johan M. Fagerli, Chief Financial Officer
+47 95 81 27 65 / johan.fagerli@observemedical.com